Genetic Signatures

Genetic Signatures Limited – Annual Report 2021 Financial Report CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 17 Consolidated Note 2021 $’000s 2020 $’000s Sales Revenue 2 28,284 11,263 Other income 4 435 2,910 Cost of materials used (8,486) (3,739) Freight on materials & finished goods (1,318) (566) Employee benefits expense (10,024) (6,671) Directors’ and consultancy fees (399) (443) Depreciation and amortisation expenses (1,425) (883) Finance costs 5 (36) (33) Scientific consumables (2,761) (1,769) Travel and accommodation (262) (327) Other expenses (2,252) (1,828) Profit/(loss) before income tax 1,756 (2,086) Income tax benefit 6 - - Profit/(loss) attributable to members of the entity 1,756 (2,086) Other comprehensive income/(loss) Items that maybe reclassified subsequently to profit or loss: Foreign Currency translation of foreign operations 20 (111) Total comprehensive income/(loss) for the year, net of tax 1,776 (2,197) Earnings (loss) per share 2021 cents 2020 cents Basic Earnings/(loss) per share to ordinary equity holders of the company 29 1.23 (1.64) Diluted Earnings/(loss) per share to ordinary equity holders of the company 29 1.21 (1.64) The above Consolidated Statement of Profit or Loss and Other Comprehensive Income should be read in conjunction with the accompanying notes Consolidated Statement of Profit or Loss and Other Comprehensive Income